Safety of ADU-1604 in Adults With Metastatic Melanoma
Clinical trial NCT03674502 · TERMINATED
Trial details
- NCT number
- NCT03674502
- Sponsor
- Aduro Biotech, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-08
- Primary completion
- 2019-08-09
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.